BOLD-100-001 (TRIO039): A phase 1b dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid cancers: Interim safety, tolerability, and efficacy Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Spratlin, Jennifer L
  • Kane, Grainne O
  • Goodwin, Rachel Anne
  • McWhirter, Elaine
  • Thompson, Darby
  • Halani, Khalif
  • Jones, Michelle
  • Snow, Malcolm
  • McAllister, Edward Russell
  • Machado, Andres
  • Lemmerick, Yasmin
  • Pankovich, Jim

publication date

  • June 1, 2022